-
Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.
-
Impulse control disorders in Parkinson's disease are associated with a unique pattern of electrophysiological activity in the ventral subthalamic nucleus.
-
Light-exacerbated pain occurring during migraine headaches is associated with increased cerebral blood flow in the visual cortex. This activation of retinal ganglion cells by light, present even in blind migraineurs, occurs through posterior thalamic connections.
-
Neurosurgical interventions for trigeminal neuralgia have never been rigorously studied for efficacy and carry significant risks.
-
Non-Hodgkin B-cell lymphomas are more likely to be associated with peripheral nerve disorders, and Hodgkin's disease with central nervous system syndromes.
-
-
-
In this issue: Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.
-
The ECG above was obtained in the office from an older woman with hypertension and atypical chest discomfort. Has there been anterior infarction, or is this a "pseudo-infarct" pattern?
-
A new antidepressant that combines selective serotonin reuptake inhibition with partial agonism of the 5-HT1A receptor has been approved by the FDA. Vilazodone is marketed by Trovis Pharmaceuticals as Viibryd(TM).